Associated Papers
IKAROS regulates human T cell phenotype at a thymic and postthymic level.
Stoddard J et al.
Jci Insight, 2025
Inborn errors of regulatory T-cell differentiation and function.
Oktelik FB et al.
The Journal of Allergy and Clinical Immunology, 2025
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia.
Stoltze U et al.
Leukemia, 2025
IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease.
Liu Q et al.
The Journal of Clinical Investigation, 2024
IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypes.
Klangkalya N et al.
Clinical Immunology (orlando, Fla.), 2024
Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency.
Kuehn HS et al.
Clinical and Experimental Immunology, 2023
Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation.
Hoshino A et al.
Science Immunology, 2022
IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma.
Barrio S et al.
Haematologica, 2020
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
Juskevicius D et al.
Journal of Hematology & Oncology, 2017
28302137 (PubMed )
Supplement: 13045_2017_438_MOESM1_ESM.xlsx › Selected_mutations_2016.08.22
Select a paper to view details